347173-47-1

Basic information

• Product Name: 4-(4-FLUOROPHENYL)-2-METHYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER
• Synonyms: 4-(4-FLUOROPHENYL)-2-METHYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER
• CAS NO: 347173-47-1
• Molecular Formula: C13H12FNO2S
• Molecular Weight: 265.3
• Mol File: 347173-47-1.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4-(4-FLUOROPHENYL)-2-METHYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-FLUOROPHENYL)-2-METHYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER(347173-47-1)
• EPA Substance Registry System: 4-(4-FLUOROPHENYL)-2-METHYL-5-THIAZOLECARBOXYLIC ACID ETHYL ESTER(347173-47-1)

Safety Data

• Hazardous Substances Data: 347173-47-1(Hazardous Substances Data)

Upstream product

• 74476-70-3 2-chloro-3-(4-fluoro-phenyl)-3-oxo-propionic acid ethyl ester 
• 62-55-5 thioacetamide 

Downstream Products

• 914287-84-6 2-methyl-5-(4-fluorophenylthiazole)-4-carboxylic acid 

Relevant articles and documents

THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially

OXAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to oxazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially

PHENETHYLAMIDE DERIVATIVES AND THEIR HETEROCYCLIC ANALOGUES

The invention relates to novel phenethylamide derivatives and their heterocyclic analogues of formula (I), wherein A, B, R1, R2 and R3 are as described in the application, and to the use of such compounds, or of pharmaceut

THIAZOLIDINE COMPOUNDS AS OREXIN RECEPTOR ANTAGONISTS

The invention relates to thiazolidine derivatives of the formula (I) wherein A, B, and R1 are as described in the description, to salts, especially pharmaceutically acceptable salts, of such compounds and to their use as medicaments, especially

TRANS-3-AZA-BICYCLO[3.1.0]HEXANE DERIVATIVES

The invention relates to novel trans-3-aza-bicyclo[3.1.0]hexane derivatives of formula (I), wherein A, B, n and R1 are as described in the description, and to the use of such compounds, or of pharmaceutically acceptable salts of such compounds, as medicaments, especially as orexin receptor antagonists.

Fused-ring compounds and use thereof as drugs

The present invention provides a fused ring compound of the following formula [I] wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. Th